Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients


A major pharmaceutical manufacturer has commissioned market research to understand the unique issues and concerns of those diagnosed CLL. Your participation in this project will help to expand on new treatments, as well as enhance awareness and improve education about Blood Cancers.
Q2 Reader Poll Results: Shared Decision Making During March through June 2019, the CLL Society conducted a poll among readers of The CLL Society Tribune. There were 84 complete responses with 94% of the responses from patients and 6% of the responses from caregivers. The respondents included 60% who are